Evaluating Treatment Response in CIDP: Clinical Precision in a Heterogeneous Disorder
Evaluation of treatment efficacy in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is inherently challenging. This complexity reflects the marked biological and clinical heterogeneity of the disorder, as well as the substantial placebo response consistently reported in clinical trials.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
